Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ligand Pharmaceuticals (LGND) Tax Rate (2016 - 2025)

Ligand Pharmaceuticals' Tax Rate history spans 16 years, with the latest figure at 21.13% for Q4 2025.

  • For Q4 2025, Tax Rate rose 43.0% year-over-year to 21.13%; the TTM value through Dec 2025 reached 21.71%, down 23842.0%, while the annual FY2025 figure was 21.71%, 23842.0% down from the prior year.
  • Tax Rate for Q4 2025 was 21.13% at Ligand Pharmaceuticals, up from 16.91% in the prior quarter.
  • Across five years, Tax Rate topped out at 160.21% in Q4 2022 and bottomed at 214.12% in Q1 2021.
  • The 5-year median for Tax Rate is 18.76% (2024), against an average of 7.13%.
  • The largest annual shift saw Tax Rate crashed -23478bps in 2021 before it skyrocketed 17273bps in 2022.
  • A 5-year view of Tax Rate shows it stood at 22.83% in 2021, then skyrocketed by 602bps to 160.21% in 2022, then plummeted by -104bps to 6.38% in 2023, then surged by 424bps to 20.69% in 2024, then grew by 2bps to 21.13% in 2025.
  • Per Business Quant, the three most recent readings for LGND's Tax Rate are 21.13% (Q4 2025), 16.91% (Q3 2025), and 56.81% (Q2 2025).